BELLIA, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 87
AS - Asia 46
SA - Sud America 24
EU - Europa 23
Totale 180
Nazione #
US - Stati Uniti d'America 82
SG - Singapore 19
BR - Brasile 16
VN - Vietnam 12
CN - Cina 9
DE - Germania 7
IT - Italia 7
AR - Argentina 4
GB - Regno Unito 4
CA - Canada 3
IN - India 3
BD - Bangladesh 2
FI - Finlandia 2
MX - Messico 2
BO - Bolivia 1
BY - Bielorussia 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ID - Indonesia 1
SE - Svezia 1
UY - Uruguay 1
Totale 180
Città #
Chandler 17
San Jose 11
Singapore 11
Munich 7
Ashburn 4
Bengaluru 3
Dallas 3
Hefei 3
Ho Chi Minh City 3
Lawrence 3
Milan 3
Princeton 3
Santa Clara 3
Goiânia 2
Hanoi 2
Hải Dương 2
New York 2
Rapallo 2
Redmond 2
São Paulo 2
Turku 2
Acerra 1
Atlanta 1
Beijing 1
Capivari 1
Carpina 1
Charqueada 1
Claymont 1
Conceição do Castelo 1
Córdoba 1
Des Moines 1
Dhaka 1
Florence 1
Formosa 1
Fortín de las Flores 1
Gaithersburg 1
Guangzhou 1
Guaratinguetá 1
Holywell 1
Iaciara 1
Jaboatão dos Guararapes 1
Juiz de Fora 1
La Paz 1
Laval 1
London 1
Lấp Vò 1
Manchester 1
Mexico City 1
Minsk 1
Montería 1
Montevideo 1
New Malden 1
Ninh Bình 1
Olomouc 1
Ottawa 1
Penápolis 1
Phoenix 1
Phủ Lý 1
Porto Alegre 1
Riobamba 1
Sorocaba 1
Subang 1
Teotônio Vilela 1
Toronto 1
Wilmington 1
Yên Bái 1
Totale 135
Nome #
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 81
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 54
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 50
Totale 185
Categoria #
all - tutte 1.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 1 0 0
2021/20226 0 0 0 1 0 0 1 1 1 0 2 0
2022/202345 6 1 2 0 8 7 2 3 9 3 4 0
2023/20245 1 2 0 0 0 0 0 0 0 0 1 1
2024/202529 5 0 0 0 2 6 0 0 0 0 7 9
2025/202693 6 17 11 18 9 3 4 3 13 9 0 0
Totale 185